Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Franse aandelen Terug naar discussie overzicht

Deinove gaat Fermentalg achterna

56 Posts
Pagina: «« 1 2 3 | Laatste | Omlaag ↓
  1. Leeser1959 23 januari 2020 11:35
    quote:

    poil-1 schreef op 10 januari 2020 15:07:

    Pfff.
    Drukt even door naar beneden.
    Ga er van uit dat de 1 euro niet wordt gebroken.
    Afwachten.
    Prettig weekend, poil
    Doe je nog wat in Deinove ?

    Met vriendelijke groet "Leeser1959"
  2. Leeser1959 24 januari 2020 13:25
    quote:

    poil-1 schreef op 23 januari 2020 19:09:

    Jazeker. Iets afgebouwd, dat wel. Maar nog zeker genoeg :).
    Groet, poil
    Volgens mij positieve ontwikkelingen bij Deinove.

    Heb op lagere koersen nog wat bijkooporders ingelegd.

  3. Leeser1959 6 februari 2020 10:25

    Sharon Laboratories capitalizes on Deinove to sustain its development activities






    06.02.2020

    •The signed Memorandum of Understanding (MoU) covers the development and marketing of an exclusive range of bio-based ingredients for personal care from DEINOVE’s platform.
    •This decisive and unprecedented agreement, to be finalized by the end of March 2020, will have an initial term of 3 years and provides for partial financing of activities and royalties on sales.
    •Even before the conclusion of the contractual agreement, Sharon Laboratories demonstrates its commitment with the immediate payment of $200k, being only a part of the substantial upfront payment to be paid after the signing of the final agreement.

    DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that uses a disruptive approach to develop innovative antibiotics and bio-based active ingredients for cosmetics, announced having signed a Memorandum of Understanding (MoU) with the Israeli group Sharon Laboratories, a specialist in preservative solutions for personal care. It aims at entering into an exclusive partnership for the development and marketing of a range of new bio-based solutions, including bioactives, arising from DEINOVE’s platform.

    Expanding the potential of DEINOVE’s platform towards advanced bio-based applications

    Sharon Laboratories is a world leader in preservative solutions for personal care. Driven by the growing consumer and brand demand for naturally and sustainably sourced ingredients, Sharon Laboratories wishes to entrust DEINOVE with joint development of a new range of bio-based and differentiated solutions.

    This collaborative R&D program will benefit from DEINOVE's accumulated expertise in leveraging the properties of its collection of rare microorganisms. It will expand the potential of DEINOVE's biotechnology platform to a substantial and promising market, building on Sharon Laboratories 40 years of experience in the personal care preservation field. The global cosmetic market is seeking natural solutions to replace existing synthetic ingredients. As the natural cosmetics segment continues to grow, the demand for such ingredients will grow with it.

    The draft agreement grants an exclusivity in various ingredient and functions to Sharon Laboratories, keeping DEINOVE's free to develop additional collaborations.

    A path-breaking partnership

    DEINOVE and Sharon Laboratories have signed an MoU for an agreement to be finalized by the end of the first quarter of 2020. This decisive agreement has an initial term of 3 years and provides for the regular payment of significant milestones, amounting to several millions of dollars, as well as royalties on sales once commercialized. Sharon Laboratories demonstrates its commitment with the immediate $200k payment.

    "This upcoming decisive and unprecedented agreement with Sharon Laboratories underlines the quality and versatility of our technological platform. Expanding into the demanding and promising new fields and functions is a great opportunity for DEINOVE. Doing so in the framework of an exclusive agreement with one of the main industry leaders, who shows his commitment already today, would ensure our success", says Charles Woler, CEO of DEINOVE.

    "We are excited to enter into this new field which we believe is the future of the cosmetic industry. Sharon Laboratories created a strong foundation for expedited growth, and we find DEINOVE to be the right partner to join us in this journey. We believe DEINOVE's technology, know-how and people align well with Sharon's strong capabilities and growth strategy", says Ari Melamud, CEO of Sharon Laboratories.
  4. Leeser1959 20 februari 2020 09:47

    DEINOVE expands its range of cosmetic active ingredients






    19.02.2020

    •Its second innovative carotenoid has the particularity of absorbing blue light, which is responsible for premature skin ageing, the appearance of skin spots, a loss of radiance and vitality.
    •Efficacy tests carried out on human skin explants confirmed its protective properties and also revealed that it plays an active role on key parameters contributing to skin lightening.
    •The new ingredient will be officially launched at in-Cosmetics Global (31 March-2 April, Barcelona).

    DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that uses a disruptive approach to develop innovative antibiotics and bio-based active ingredients for cosmetics, confirms being in the process of finalizing the development of its 2nd proprietary cosmetic active ingredient, for its official launch at the upcoming in-Cosmetics Global trade show.

    DEINOVE has developed a new cosmetic active ingredient, produced by fermentation and based on a totally original carotenoid, designed to restore radiance and vitality to the skin.

    Its ability to absorb blue light* and its outstanding antioxidant properties had been demonstrated in vitro.

    Ex vivo studies have since been carried out, confirming these properties and revealing additional features, particularly in terms of complexion homogeneity and brightness, which are particularly sought by the cosmetics industry.

    The active is currently being clinically tested and data will be available for the official launch.

    "We are actively preparing the launch of this 2nd proprietary active ingredient which will be officially presented at in-Cosmetics Global, the world's largest trade show dedicated to cosmetic ingredients, taking place in Barcelona from March 31 to April 2. After a promising preview at in-Cosmetics Asia last fall, we will be able to present robust data demonstrating the efficacy and original mechanism of action of this active ingredient, " says Coralie MARTIN, Marketing Manager at DEINOVE.



    * Blue light is emitted not only by the sun, but also by screens (TV, computers, smartphones, tablets), electronics and lighting. This light radiation is known for its harmful effects on the health and beauty of the skin. Digital pollution is an emerging issue in cosmetics, given the increasing exposure to blue light produced by screens or LEDs.

    ? PR in English
  5. [verwijderd] 21 februari 2020 12:20
    Deinove 0,995 0,059 6,30 % 12:16:17

    Voor het laatst onder de euro.
    Het is nu tijd (zeker na het goede nieuws van deze maand) om weer een forse stap hoger te zetten.
    Succes, poil
  6. [verwijderd] 21 februari 2020 12:35
    Deinove - Phase II study with DNV3837 for C. diff starts
    Deinove reported that the first patient has been enrolled in its Phase II study with a novel quinolonyl-oxazolidinone class antibiotic DNV3837 for moderate to severe C. diff infections. The results are expected by the end of 2020, which will be a substantial catalyst for the share price. The company also reported multiple developments in its bioactives portfolio, including a new substantial collaboration with a partner that has experience in commercialising preservative solutions for personal care products. We have slightly increased our valuation to €78m or €4.6/share.
  7. [verwijderd] 21 februari 2020 12:46
    Ik verwacht dat we vandaag nog wel richting de 1,15 - 1,20 kunnen gaan.
    Ik verwacht de aankomende periode een fors herstel. Koersdoel 4,60 !
    Succes, poil
  8. [verwijderd] 21 februari 2020 13:14
    Alle signalen staan op groen.
    Een spelbreker ;) zet de koers nog even op 98.
    Straks gaat het pas echt los.
    Ik neem nu al een biertje op de 25% plus van vandaag!
    Succes, poil
  9. Leeser1959 21 februari 2020 13:21
    quote:

    poil-1 schreef op 21 februari 2020 13:14:

    Alle signalen staan op groen.
    Een spelbreker ;) zet de koers nog even op 98.
    Straks gaat het pas echt los.
    Ik neem nu al een biertje op de 25% plus van vandaag!
    Succes, poil
    Rustig aan poil-1, e komen doorlopend nieuwe aandelen bij vanuit de convertible !!

    Ik ben overigens zeker positief.
56 Posts
Pagina: «« 1 2 3 | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.158
AB InBev 2 5.544
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 52.476
ABO-Group 1 25
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.930
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 193
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.890
Aedifica 3 927
Aegon 3.258 323.201
AFC Ajax 538 7.092
Affimed NV 2 6.306
ageas 5.844 109.908
Agfa-Gevaert 14 2.074
Ahold 3.538 74.357
Air France - KLM 1.025 35.321
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.057
Alfen 16 25.483
Allfunds Group 4 1.523
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 426
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 244.230
AMG 972 134.714
AMS 3 73
Amsterdam Commodities 305 6.753
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 501
Antonov 22.632 153.605
Aperam 92 15.103
Apollo Alternative Assets 1 17
Apple 5 387
Arcadis 252 8.808
Arcelor Mittal 2.035 321.075
Archos 1 1
Arcona Property Fund 1 287
arGEN-X 17 10.375
Aroundtown SA 1 221
Arrowhead Research 5 9.757
Ascencio 1 30
ASIT biotech 2 697
ASMI 4.108 39.691
ASML 1.767 112.032
ASR Nederland 21 4.522
ATAI Life Sciences 1 7
Atenor Group 1 522
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 14.322
Axsome Therapeutics 1 177
Azelis Group 1 67
Azerion 7 3.463

Macro & Bedrijfsagenda

  1. 10 april

    1. Consumenten- en producentenprijzen, maart (Chi)
    2. Industriële productie, februari (NL)
    3. Fagron cijfers eerste kwartaal en beleggersdag
    4. Aalberts jaarvergadering
    5. Van Lanschot Kempen bava (kapitaalteruggave)
    6. Inflatie, maart (VS) volitaliteit verwacht
    7. Steunaanvragen - wekelijks (VS)
    8. TSMC, omzetcijfers maart
  2. 11 april

    1. Faillissementen, maart (NL)
    2. Inflatie, maart (Dld)
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht